Precision Antimicrobial Therapy Against Fusobacterium nucleatum Using Bioengineered Probiotics Expressing Guided Antimicrobial Peptides (gAMPs).
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Precision Antimicrobial Therapy Against Fusobacterium nucleatum Using Bioengineered Probiotics Expressing Guided Antimicrobial Peptides (gAMPs).
- Published In:
- Microbial biotechnology, 18(12), e70241 (2025)
- Authors:
- Choudhury, Ankan, Scano, Colin, Barton, Allison, Kearney, Christopher M, Greathouse, K Leigh
- Database ID:
- RPEP-10479
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10479APA
Choudhury, Ankan; Scano, Colin; Barton, Allison; Kearney, Christopher M; Greathouse, K Leigh. (2025). Precision Antimicrobial Therapy Against Fusobacterium nucleatum Using Bioengineered Probiotics Expressing Guided Antimicrobial Peptides (gAMPs).. Microbial biotechnology, 18(12), e70241. https://doi.org/10.1111/1751-7915.70241
MLA
Choudhury, Ankan, et al. "Precision Antimicrobial Therapy Against Fusobacterium nucleatum Using Bioengineered Probiotics Expressing Guided Antimicrobial Peptides (gAMPs).." Microbial biotechnology, 2025. https://doi.org/10.1111/1751-7915.70241
RethinkPeptides
RethinkPeptides Research Database. "Precision Antimicrobial Therapy Against Fusobacterium nuclea..." RPEP-10479. Retrieved from https://rethinkpeptides.com/research/choudhury-2025-precision-antimicrobial-therapy-against
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.